KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹65 Cr | ₹55 Cr | ₹42 Cr | ₹67 Cr | ₹63 Cr |
What is the latest Total Non-Current Liabilities ratio of KERALA AYURVEDA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹65 Cr |
Mar2023 | ₹55 Cr |
Mar2022 | ₹42 Cr |
Mar2021 | ₹67 Cr |
Mar2020 | ₹63 Cr |
How is Total Non-Current Liabilities of KERALA AYURVEDA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹65 Cr | 19.29 | |
Mar2023 | ₹55 Cr | 30.65 | |
Mar2022 | ₹42 Cr | -37.36 | |
Mar2021 | ₹67 Cr | 6.55 | |
Mar2020 | ₹63 Cr | - |
Compare Total Non-Current Liabilities of peers of KERALA AYURVEDA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KERALA AYURVEDA | ₹703.9 Cr | 2.9% | 21.4% | 48.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
KERALA AYURVEDA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KERALA AYURVEDA | 2.9% |
21.4% |
48.5% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses